Human TNFRSF9 (Tumor Necrosis Factor Receptor Superfamily Member 9) Antibody Pair (STJAP00382)

SKU:
STJAP00382-50

Shipping:
Free Shipping
Current Stock:
Host: Goat/Goat
Applications: ELISA
Reactivity: Human
Note: FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS.
Short Description: This TNFRSF9 antibody pair contains complimentary capture and detection antibodies, which work together under the principals of the Sandwich ELISA.
Conjugation: Unconjugated/Biotin
Formulation: Capture Buffer: PBS with 0.04% Proclin 300; 50% glycerol; pH 7.5.
Detection Buffer: PBS with 0.04% Proclin 300; 1% protective protein; 50% glycerol; pH 7.5.
Purification: Capture Purification: Antigen Affinity.
Detection Purification: Antigen Affinity.
Concentration: 0.5 mg/mL
Storage Instruction: Store at-20°C for long term, and avoid freeze-thaw cycles.
Determination Method: Colormetric
Gene Symbol: TNFRSF9
Gene ID: 3604
Uniprot ID: TNR9_HUMAN
Immunogen: Capture immunogen: Recombinant Human TNFRSF9 protien.
Detection Immunogen: Recombinant Human TNFRSF9 protien.
Sample Type: Serum, plasma and other biological fluids
Function Receptor for TNFSF9/4-1BBL. Conveys a signal that enhances CD8(+) T-cell survival, cytotoxicity, and mitochondrial activity, thereby promoting immunity against viruses and tumors (Probable).
Protein Name Tumor Necrosis Factor Receptor Superfamily Member 9
4-1bb Ligand Receptor
Cdw137
T-Cell Antigen 4-1bb Homolog
T-Cell Antigen Ila
Cd Antigen Cd137
Database Links Reactome: R-HSA-5669034
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Alternative Antibody Pair Names Tumor Necrosis Factor Receptor Superfamily Member 9 antibody pair
4-1bb Ligand Receptor antibody pair
Cdw137 antibody pair
T-Cell Antigen 4-1bb Homolog antibody pair
T-Cell Antigen Ila antibody pair
Cd Antigen Cd137 antibody pair
TNFRSF9 antibody pair
CD137 antibody pair
ILA antibody pair

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance